assay (Figure 4) . Presumably, the antibody of the NML method crossreacts significantly with human choriogonadotropin, which is highly increased in serum during pregnancy(5).
New Test for Urinary Glucose (BM33071) Evaluated
David L Smalley and Mary E. Bradley 
Materials and Methods
We evaluated the performance of the glucose pad "BM33071" hydrogen peroxide with a potassium iodide chromogen to oxidize a chromogen to color changes from green to brown with increasing glucose concentrations. For a quantitative comparison method, we used a hexokinase/glucose-6-phosphate dehydrogenase procedure (1) with a centrifugal analyzer (Multistat III), and reagents from Instrumentation Laboratory, Lexington,
MA 02173. The accuracy of this method has previously been established (2); however, we also included aqueous glucose controls (0.5 and 1.5 g/L) with each batch of urine samples tested.
For method correlation we used 500 freshly collected patients' urines, selected to provide a range of glucose concentrations, refrigerating them at 4 #{176}C until analysis (not more than 5 h). We tested each urine with the BM33071 strips, reading the color reaction 1 mm after immersion, and with Hema-Combistix, reading the color reaction at 30 s after immersion, both as recommended by the manufacturers. The time between dipstick analysis and the hexokinase comparison method never exceeded 30 mm.
To establish the practical level of sensitivity for the glucose test on the BM33071, we used the procedure suggested by Kutter (3). The practical sensitivity, which allows the quantitative assessment of the analytical detection limit for diagnostic tests with a yes/no answer, is expressed as that specific concentration of an analyte in a body fluid that causes a positive result in 90% of all tested samples. We tested 20 fresh urine samples that were separated into six portions and had glucose added to give a final concentration of 0, 200, 300, 400, 500, and 600 mgfL. The urines were arranged in random order and the BM33071 glucose reaction was read on each by three separate technologists. Every reaction color clearly distinguishable from the negative label was considered as positive.
Interference with glucose color reactions was investigated for 10 fresh urine samples, separated into four portions each. To all portions we added glucose to give a final concentration of 1 . All portions were tested with both the BM33071 and the Hema-Combistix glucose tests.
Because ascorbic acid has been shown to interfere with other tests on urine chemistry strips (4), we also evaluated the effect of ascorbic acid on the glucose pad ofBM33O7l. To 10 fresh urines with a negative ascorbic acid test result (by C-Stix from Ames) and a relative density of 1.020 or greater, we added glucose to give a final concentration of 1.0 or 5.0 g/ L. Each urine was divided into four portions and ascorbic acid added to give a final concentration of 0, 100,200, or 400 mg/L. All portions were then tested with both strips.
Results and Discussion
Method correlation: Calculated values of G, and the corresponding 95% confidence intervals, for BM33071 were 0.996 (0.994-0.998) and for Hema-Combistix glucose were 0.978 (0.968-0.988). As shown by the non-overlapping confidence intervals, results by the BM33071 method displayed stronger association with those by the hexokinase method than did those by the Hema-Combistix glucose test.
As indicated in Figure 1 , glucose concentrations in 73.4% of the urines estimated by BM33071 agreed with the hexokinase method results, 2.6% were lower and 24% were higher; however, the deviation never exceeded one color block on the label. Hema-Combistix results agreed with the hexokinase method results in 68.8% of the urine samples, 5% were lower, and 26.2% were higher; values for six urines (1.2%) deviated by more than one comparison color.
Practical sensitivity: Figure 2 shows the practical sensitivity curves for the BM33071. The average level of sensitivity was 260 mg/L at the 90% positive level, as described by Kutter On the basis of these interference data, we predict that the BM33071 would not present false-negative results under the conditions studied. The effect of ascorbic acid should be minimal, given the normal excreted concentration of ascorbic acid of usually less than 0.25 gIL.
Indican Interference with Six Commercial Procedures for Measuring Total Bilirubin

R. Poon and I. H. Hlnberg1
We have studied the effect of indican on six commercial procedures for the measurement of total bilirubin in serum. We have studied the effect of indican on six commercial colorimetric procedures for the measurement of total bilirubin in serum and report our findings. We prepared samples with indican concentrations between 0 and 0.92 mmol/L by adding appropriate volumes of a 47 mmol/L solution of indican to aliquots of pooled human serum. The manual and automated colorimetric bilirubin measurement procedures we studied are described in Table  1 . The kit manufacturers' directions for use were strictly followed. Where calibrators were not provided, we used bilirubin standards in bovine serum albumin, 40 g/L, prepared as described by Perry et al. (5).
Materials and Methods
Indican
Stabilizer-free 2,4-DCPD reagent was prepared at room temperature by adding sodium nitrite (final concentration, 10 MlnolJL) to a solution containing 2 minol of 2,4-dichloroaniline and 69 minol of sulfamic acid per liter of water! methanol (1/1, by vol) . We used the reagent 2 mm after adding the sodium nitrite.
To measure absorbance, we used a Beckman DU-8B spectrophotometer (Beckman Instruments Inc., Fullerton, CA 92634); difference spectra were obtained with a Cary 219 spectrophotometer (Varian Associates Inc., Palo Alto, CA 94303).
